Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Jones

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|August 30, 2025
Estimating the benefits of personalised glycaemic control - Authors' replyPedro Cardoso, Trevelyan J McKinley, Angus G Jones, et al.
Clinical Medicine (London, England)|February 3, 2017
Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictiveAli J Chakera, Timothy J McDonald, Bridget A Knight, et al.
Diabetes Care|May 21, 2021
Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) DiabetesAngus G Jones, Timothy J McDonald, Beverley M Shields, et al.
Plos One|October 24, 2014
Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicineAngus G Jones, Beverley M Shields, Christopher J Hyde, et al.
Clinical Diabetes and Endocrinology|February 21, 2019
Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative reviewDavis Kibirige, William Lumu, Angus G Jones, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2019
Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' replyJohn M Dennis, Beverley M Shields, William E Henley, et al.
The Lancet. Diabetes & Endocrinology|May 4, 2019
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial dataJohn M Dennis, Beverley M Shields, William E Henley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2011
A novel case of a raised testosterone and LH in a young manTim J McDonald, Mandy H Perry, Angus G Jones, et al.
Diabetes Care|August 27, 2024
Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570Pedro Cardoso, Katie G Young, Andrew T Hattersley, et al.
Diabetologia|February 9, 2022
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetesDavis Kibirige, Isaac Sekitoleko, William Lumu, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|August 30, 2025
Estimating the benefits of personalised glycaemic control - Authors' replyPedro Cardoso, Trevelyan J McKinley, Angus G Jones, et al.
Clinical Medicine (London, England)|February 3, 2017
Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictiveAli J Chakera, Timothy J McDonald, Bridget A Knight, et al.
Diabetes Care|May 21, 2021
Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) DiabetesAngus G Jones, Timothy J McDonald, Beverley M Shields, et al.
Plos One|October 24, 2014
Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicineAngus G Jones, Beverley M Shields, Christopher J Hyde, et al.
Clinical Diabetes and Endocrinology|February 21, 2019
Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative reviewDavis Kibirige, William Lumu, Angus G Jones, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2019
Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' replyJohn M Dennis, Beverley M Shields, William E Henley, et al.
The Lancet. Diabetes & Endocrinology|May 4, 2019
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial dataJohn M Dennis, Beverley M Shields, William E Henley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 16, 2011
A novel case of a raised testosterone and LH in a young manTim J McDonald, Mandy H Perry, Angus G Jones, et al.
Diabetes Care|August 27, 2024
Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570Pedro Cardoso, Katie G Young, Andrew T Hattersley, et al.
Diabetologia|February 9, 2022
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetesDavis Kibirige, Isaac Sekitoleko, William Lumu, et al.
Pageof 10